DK1496865T3 - Fremgangsmåde til fremstilling af krystaller, ifölge denne opnåelige krystaller og deres anvendelse i farmaceutiske formuleringer - Google Patents
Fremgangsmåde til fremstilling af krystaller, ifölge denne opnåelige krystaller og deres anvendelse i farmaceutiske formuleringerInfo
- Publication number
- DK1496865T3 DK1496865T3 DK03730046T DK03730046T DK1496865T3 DK 1496865 T3 DK1496865 T3 DK 1496865T3 DK 03730046 T DK03730046 T DK 03730046T DK 03730046 T DK03730046 T DK 03730046T DK 1496865 T3 DK1496865 T3 DK 1496865T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystals
- mum
- obtainable
- preparation
- pharmaceutical formulations
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 2
- 238000001238 wet grinding Methods 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000011164 primary particle Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10218109A DE10218109A1 (de) | 2002-04-23 | 2002-04-23 | Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1496865T3 true DK1496865T3 (da) | 2006-10-09 |
Family
ID=29264788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03730046T DK1496865T3 (da) | 2002-04-23 | 2003-04-22 | Fremgangsmåde til fremstilling af krystaller, ifölge denne opnåelige krystaller og deres anvendelse i farmaceutiske formuleringer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7192942B2 (fr) |
| EP (1) | EP1496865B1 (fr) |
| JP (1) | JP4490114B2 (fr) |
| KR (1) | KR20040106379A (fr) |
| CN (1) | CN1646101A (fr) |
| AT (1) | ATE332686T1 (fr) |
| AU (1) | AU2003240652A1 (fr) |
| BR (1) | BR0308744A (fr) |
| CA (1) | CA2479991C (fr) |
| DE (2) | DE10218109A1 (fr) |
| DK (1) | DK1496865T3 (fr) |
| ES (1) | ES2268368T3 (fr) |
| IL (1) | IL163985A0 (fr) |
| MX (1) | MXPA04010468A (fr) |
| NO (1) | NO20045073L (fr) |
| PL (1) | PL371339A1 (fr) |
| PT (1) | PT1496865E (fr) |
| RU (1) | RU2314315C2 (fr) |
| WO (1) | WO2003090714A1 (fr) |
| ZA (1) | ZA200409395B (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10218107A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| EP1993513A4 (fr) * | 2006-03-14 | 2012-06-27 | Merck Sharp & Dohme | Procédés et appareils permettant de produire des compositions de microparticules organiques cristallines par micro-broyage et cristallisation sur micro-grain et utilisation correspondante |
| DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| RU2464321C2 (ru) * | 2010-12-20 | 2012-10-20 | Федеральное государственное образовательное учреждение высшего профессионального образования "Вологодская государственная молочнохозяйственная академия им. Н.В. Верещагина" | Способ производства молочного сахара |
| RS62297B1 (sr) | 2011-11-23 | 2021-09-30 | Therapeuticsmd Inc | Prirodne kombinovane hormonske supstitucione formulacije i terapije |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． | 天然の併用ホルモン補充療法剤及び療法 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| JP7029875B1 (ja) | 2020-05-15 | 2022-03-04 | 塩野義製薬株式会社 | 不純物の生成を抑制した医薬組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD275398B5 (de) | 1988-09-07 | 1993-12-23 | Dresden Arzneimittel | Verfahren zur herstellung von feinverteilten pharmazeutischen wirkstoffen |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| NZ248813A (en) * | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
| DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| JP3428021B2 (ja) * | 1993-12-27 | 2003-07-22 | 日本曹達株式会社 | ４−ヒドロキシ−４’−イソプロポキシジフェニルスルホン顕色用組成物，湿式粉砕方法及び分散液 |
| US5718388A (en) * | 1994-05-25 | 1998-02-17 | Eastman Kodak | Continuous method of grinding pharmaceutical substances |
| US5534270A (en) * | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
| WO1998057648A1 (fr) | 1997-06-16 | 1998-12-23 | Vertex Pharmaceuticals Incorporated | Procede d'amelioration de la biodisponibilite des polymorphes cristallins stables d'un compose |
| AU1798300A (en) * | 1998-12-25 | 2000-07-31 | Fuji Chemical Industries, Ltd. | Method for producing calcium pantothenate |
| EP1157996A1 (fr) * | 2000-05-23 | 2001-11-28 | JENAPHARM GmbH | Nouveaux formes solides du mesoprogestin 11beta-(4E-(hxdroxyiminomethyl)-phenyl)-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on |
| DE10218107A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
-
2002
- 2002-04-23 DE DE10218109A patent/DE10218109A1/de not_active Ceased
-
2003
- 2003-04-17 US US10/417,559 patent/US7192942B2/en not_active Expired - Lifetime
- 2003-04-22 DK DK03730046T patent/DK1496865T3/da active
- 2003-04-22 ES ES03730046T patent/ES2268368T3/es not_active Expired - Lifetime
- 2003-04-22 WO PCT/EP2003/005102 patent/WO2003090714A1/fr not_active Ceased
- 2003-04-22 PT PT03730046T patent/PT1496865E/pt unknown
- 2003-04-22 AT AT03730046T patent/ATE332686T1/de not_active IP Right Cessation
- 2003-04-22 IL IL16398503A patent/IL163985A0/xx unknown
- 2003-04-22 PL PL03371339A patent/PL371339A1/xx not_active Application Discontinuation
- 2003-04-22 CA CA2479991A patent/CA2479991C/fr not_active Expired - Lifetime
- 2003-04-22 JP JP2003587351A patent/JP4490114B2/ja not_active Expired - Fee Related
- 2003-04-22 RU RU2004134327/04A patent/RU2314315C2/ru not_active IP Right Cessation
- 2003-04-22 AU AU2003240652A patent/AU2003240652A1/en not_active Abandoned
- 2003-04-22 DE DE50304230T patent/DE50304230D1/de not_active Expired - Lifetime
- 2003-04-22 EP EP03730046A patent/EP1496865B1/fr not_active Expired - Lifetime
- 2003-04-22 MX MXPA04010468A patent/MXPA04010468A/es active IP Right Grant
- 2003-04-22 BR BR0308744-1A patent/BR0308744A/pt not_active IP Right Cessation
- 2003-04-22 KR KR10-2004-7017078A patent/KR20040106379A/ko not_active Withdrawn
- 2003-04-22 CN CNA038090341A patent/CN1646101A/zh active Pending
-
2004
- 2004-11-22 NO NO20045073A patent/NO20045073L/no not_active Application Discontinuation
- 2004-11-22 ZA ZA200409395A patent/ZA200409395B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0308744A (pt) | 2005-01-11 |
| CA2479991A1 (fr) | 2003-11-06 |
| US20030225050A1 (en) | 2003-12-04 |
| US7192942B2 (en) | 2007-03-20 |
| CN1646101A (zh) | 2005-07-27 |
| EP1496865A1 (fr) | 2005-01-19 |
| ATE332686T1 (de) | 2006-08-15 |
| CA2479991C (fr) | 2010-06-22 |
| EP1496865B1 (fr) | 2006-07-12 |
| PL371339A1 (en) | 2005-06-13 |
| KR20040106379A (ko) | 2004-12-17 |
| ZA200409395B (en) | 2006-02-22 |
| RU2004134327A (ru) | 2006-02-27 |
| PT1496865E (pt) | 2006-10-31 |
| RU2314315C2 (ru) | 2008-01-10 |
| NO20045073L (no) | 2004-11-22 |
| IL163985A0 (en) | 2005-12-18 |
| ES2268368T3 (es) | 2007-03-16 |
| JP2005523333A (ja) | 2005-08-04 |
| JP4490114B2 (ja) | 2010-06-23 |
| DE50304230D1 (de) | 2006-08-24 |
| MXPA04010468A (es) | 2004-12-13 |
| DE10218109A1 (de) | 2003-11-20 |
| WO2003090714A1 (fr) | 2003-11-06 |
| AU2003240652A1 (en) | 2003-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1496865T3 (da) | Fremgangsmåde til fremstilling af krystaller, ifölge denne opnåelige krystaller og deres anvendelse i farmaceutiske formuleringer | |
| DK1427708T3 (da) | Amino-phthalazinon-derivater som kinase-inhibitorer, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger der indeholder det samme | |
| SI1358184T1 (sl) | N-(3,3-dimetilindolin-6-il)(2-((4-piridilmetil)amino) (3-piridil))karboksamid in njegovi farmacevtski sestavki | |
| BR0013277A (pt) | Derivados de 3(5) ureido-pirazol, processo para sua preparação e uso dos mesmos como agentes antitumorais | |
| DK0503548T3 (da) | Cykliske ureaderivater, lægemidler indeholdende disse, og fremgangsmåde til deres fremstilling. | |
| IS7965A (is) | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi | |
| WO2002068406A3 (fr) | Derives d'amines substituees et procede d'utilisation | |
| NO20085078L (no) | Nye forbindelser | |
| LU92146I2 (fr) | Dasatinib et ses sels pharmaceutiquement acceptables | |
| EE200200091A (et) | N-heterotsüklilised derivaadid kui NOSi inhibiitorid | |
| NO20021859L (no) | Nye oligosakkarider, deres fremstilling samt farmasöytiske preparater inneholdende oligosakkaridene | |
| DK297483A (da) | Fremgangsmaade til fremstilling af derivater af 9-(2-hydroxyethoxymethyl)guanin | |
| DK1497308T3 (da) | Fremgangsmåde til fremstilling af krystaller af steroider, krystaller opnået ved hjælp heraf og anvendelse heraf i farmaceutiske formuleringer | |
| WO2004093800A3 (fr) | Derives de thyronamine et analogues et des methodes d'utilisation de ces composes | |
| NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
| NO20064160L (no) | Nye azaibicykliske forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| DK0434057T3 (da) | Indocarbazol-derivater, fremgangsmåder til deres fremstilling og deres anvendelse | |
| DK0521768T3 (da) | Nye triazolopyrimidin-derivater som er angiotensin II-receptor-antagonister, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf | |
| MY141011A (en) | Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones | |
| ES8505379A1 (es) | Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos | |
| EA200400690A1 (ru) | Нуклеозиды, их препараты и их применение в качестве ингибиторов вирусных рнк-полимераз | |
| NO995431L (no) | Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse | |
| EA200600046A1 (ru) | Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции | |
| CA2239282A1 (fr) | Iso-indolones condensees utilisees comme inhibiteurs de la proteine kinase c | |
| DK0583338T3 (da) | Fremgangsmåde til syntese af peptider, hidtil ukendte aminosyrederivater anvendt i denne fremgangsmåde og fremgangsmåder til deres fremstilling |